Effects of prenatal dexamethasone exposure on adult C57BL/6J mouse metabolism and oxidative stress

• Published in: Canadian journal of physiology and pharmacology Vol. 102; no. 3; p. 180
• Main Authors: Nemec-Bakk, A S, Bel, J, Niccoli, S, Boreham, D R, Tai, T C, Lees, S J, Khaper, N
• Format: Journal Article
• Language: English
• Published: Canada 01.03.2024
• Subjects: HPA axis; HOMA IR; glucose uptake; liver; cardiac
• ISSN: 1205-7541
• DOI: 10.1139/cjpp-2023-0254

Prenatal glucocorticoid exposure has been shown to alter hypothalamic-pituitary-adrenal axis function resulting in altered fetal development that can persist through adulthood. Fetal exposure to excess dexamethasone, a synthetic glucocorticoid, has been shown to alter adult behaviour and metabolism. This study investigated the effects prenatal dexamethasone exposure had on adult offspring cardiac and liver metabolism and oxidative stress. Pregnant C57BL/6 mice received a dose of 0.4 mg/kg dexamethasone on gestational days 15-17. Once pups were approximately 7 months old, glucose uptake was determined using positron emission tomography and insulin resistance (IR) was determined by homeostatic model assessment (HOMA) IR calculation. Oxidative stress was assessed by measuring 4-hydroxynonenal protein adduct formation and total reactive oxygen species. Female dexamethasone group had significantly increased glucose uptake when insulin stimulated compared to vehicle-treated mice. HOMA IR revealed no evidence of IR in either male or female offspring. There was also no change in oxidative stress markers in either cardiac or liver tissues of male or female offspring. These data suggest that prenatal dexamethasone exposure in male mice does not alter oxidative stress or metabolism. However, prenatal dexamethasone exposure increased glucocorticoids, cardiac glucose uptake, and pAkt signaling in female heart tissues in adult mice, suggesting there are sex differences in prenatal dexamethasone exposure.